Design of COVID-19 Staged Alert Systems to Ensure Healthcare Capacity with Minimal Closures
Community mitigation strategies to combat COVID-19, ranging from healthy hygiene to shelter-in-place orders, exact substantial socioeconomic costs. Judicious implementation and relaxation of restrictions amplify their public health benefits while reducing costs. We derive optimal strategies for toggling between mitigation stages using daily COVID-19 hospital admissions. With public compliance, the policy triggers ensure adequate intensive care unit capacity with high probability while minimizing the duration of strict mitigation measures. In comparison, we show that other sensible COVID-19 staging policies, including France's ICU-based thresholds and a widely adopted indicator for reopening schools and businesses, require overly restrictive measures or trigger strict stages too late to avert catastrophic surges. As cities worldwide face future pandemic waves, our findings provide a robust strategy for tracking COVID-19 hospital admissions as an early indicator of hospital surges and enacting staged measures to ensure integrity of the health system, safety of the health workforce, and public confidence.
Errataetall: |
UpdateIn: Nat Commun. 2021 Jun 18;12(1):3767. - PMID 34145252 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - year:2020 |
---|---|
Enthalten in: |
medRxiv : the preprint server for health sciences - (2020) vom: 24. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yang, Haoxiang [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 10.11.2023 published: Electronic UpdateIn: Nat Commun. 2021 Jun 18;12(1):3767. - PMID 34145252 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1101/2020.11.26.20152520 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM318355361 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM318355361 | ||
003 | DE-627 | ||
005 | 20231225165201.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2020.11.26.20152520 |2 doi | |
028 | 5 | 2 | |a pubmed24n1061.xml |
035 | |a (DE-627)NLM318355361 | ||
035 | |a (NLM)33269372 | ||
035 | |a (PII)2020.11.26.20152520 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yang, Haoxiang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Design of COVID-19 Staged Alert Systems to Ensure Healthcare Capacity with Minimal Closures |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 10.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a UpdateIn: Nat Commun. 2021 Jun 18;12(1):3767. - PMID 34145252 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Community mitigation strategies to combat COVID-19, ranging from healthy hygiene to shelter-in-place orders, exact substantial socioeconomic costs. Judicious implementation and relaxation of restrictions amplify their public health benefits while reducing costs. We derive optimal strategies for toggling between mitigation stages using daily COVID-19 hospital admissions. With public compliance, the policy triggers ensure adequate intensive care unit capacity with high probability while minimizing the duration of strict mitigation measures. In comparison, we show that other sensible COVID-19 staging policies, including France's ICU-based thresholds and a widely adopted indicator for reopening schools and businesses, require overly restrictive measures or trigger strict stages too late to avert catastrophic surges. As cities worldwide face future pandemic waves, our findings provide a robust strategy for tracking COVID-19 hospital admissions as an early indicator of hospital surges and enacting staged measures to ensure integrity of the health system, safety of the health workforce, and public confidence | ||
650 | 4 | |a Preprint | |
700 | 1 | |a Sürer, Özge |e verfasserin |4 aut | |
700 | 1 | |a Duque, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Morton, David P |e verfasserin |4 aut | |
700 | 1 | |a Singh, Bismark |e verfasserin |4 aut | |
700 | 1 | |a Fox, Spencer J |e verfasserin |4 aut | |
700 | 1 | |a Pasco, Remy |e verfasserin |4 aut | |
700 | 1 | |a Pierce, Kelly |e verfasserin |4 aut | |
700 | 1 | |a Rathouz, Paul |e verfasserin |4 aut | |
700 | 1 | |a Du, Zhanwei |e verfasserin |4 aut | |
700 | 1 | |a Pignone, Michael |e verfasserin |4 aut | |
700 | 1 | |a Escott, Mark E |e verfasserin |4 aut | |
700 | 1 | |a Adler, Stephen I |e verfasserin |4 aut | |
700 | 1 | |a Johnston, S Claiborne |e verfasserin |4 aut | |
700 | 1 | |a Meyers, Lauren Ancel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t medRxiv : the preprint server for health sciences |d 2020 |g (2020) vom: 24. Dez. |w (DE-627)NLM310900166 |7 nnns |
773 | 1 | 8 | |g year:2020 |g day:24 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.11.26.20152520 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2020 |b 24 |c 12 |